Key Points
- To determine whether adverse cardiovascular outcomes in patients with coronary artery disease stem from the combined synergy of negative affectivity and social inhibition or from either trait independently.
- Followed 541 patients with coronary artery disease over a 5-year period using the 14-item Type D Scale.
- Evaluated the Type D construct using both a continuous interaction of negative affectivity and social inhibition z scores and a dichotomous four-group classification with a cutoff score of 10.
- Tracked endpoints of major adverse cardiac events (MACE; death, myocardial infarction, revascularization) and the combined endpoint of cardiac death or myocardial infarction.
- During follow-up, 113 patients experienced MACE and 47 experienced cardiac death or myocardial infarction.
- Continuous interaction of negative affectivity and social inhibition independently predicted MACE (OR = 1.36, 95% CI = 1.11–1.67) and cardiac death/myocardial infarction (OR = 1.48, 95% CI = 1.11–1.96) after controlling for disease severity, demographics, and depressive symptoms.
- Dichotomized Type D personality was associated with an adjusted OR of 1.74 (95% CI = 1.11–2.73) for MACE and an OR of 2.35 (95% CI = 1.26–4.38) for cardiac death/myocardial infarction, whereas high levels of either trait alone conferred no increased risk.
Structured PICO
Does the Type D personality construct (negative affectivity and social inhibition) predict cardiovascular events and mortality in patients with coronary artery disease?
PPopulation541 patients with coronary artery disease (CAD)
IInterventionType D personality construct (combination of negative affectivity [NA] and social inhibition [SI])
CComparatorPatients with high NA or SI alone, or low trait scores
OOutcomeMajor adverse cardiac events (MACEs; death, myocardial infarction [MI], coronary revascularization) and cardiac death/MI at 5-year follow-upcomposite
The Type D personality construct, characterized by the combination of negative affectivity and social inhibition, is an independent predictor of major adverse cardiac events and mortality in patients with coronary artery disease.